When a company has generated a lot of excitement -- like MAKO Surgical (NASDAQ:MAKO) has with its disruptive product and interesting growth story -- and then takes a big hit in share price, it's worth a closer look to see what's going on. In this video, Motley Fool health care bureau chief Brenton Flynn takes a more in-depth look at the company and gives you some reasons you should consider being bullish on MAKO -- and some reasons not to be.
Motley Fool Returns
Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.
Stock Advisor launched in February of 2002. Returns as of 10/25/2021.
Average returns of all recommendations since inception. Cost basis and return based on previous market day close.